Abstract:AlphaFold2 (AF2) and RoseTTaFold (RF) have revolutionized structural biology, serving as highly reliable and effective methods for predicting protein structures. This article explores their impact and limitations, focusing on their integration into experimental pipelines and their application in diverse protein classes, including membrane proteins, intrinsically disordered proteins (IDPs), and oligomers. In experimental pipelines, AF2 models help X-ray crystallography in resolving the phase problem, while complementarity with mass spectrometry and NMR data enhances structure determination and protein flexibility prediction. Predicting the structure of membrane proteins remains challenging for both AF2 and RF due to difficulties in capturing conformational ensembles and interactions with the membrane. Improvements in incorporating membrane-specific features and predicting the structural effect of mutations are crucial. For intrinsically disordered proteins, AF2's confidence score (pLDDT) serves as a competitive disorder predictor, but integrative approaches including molecular dynamics (MD) simulations or hydrophobic cluster analyses are advocated for accurate dynamics representation. AF2 and RF show promising results for oligomeric models, outperforming traditional docking methods, with AlphaFold-Multimer showing improved performance. However, some caveats remain in particular for membrane proteins. Real-life examples demonstrate AF2's predictive capabilities in unknown protein structures, but models should be evaluated for their agreement with experimental data. Furthermore, AF2 models can be used complementarily with MD simulations. In this Perspective, we propose a "wish list" for improving deep-learning-based protein folding prediction models, including using experimental data as constraints and modifying models with binding partners or post-translational modifications. Additionally, a meta-tool for ranking and suggesting composite models is suggested, driving future advancements in this rapidly evolving field.

In Silico Structural Analysis Exploring Conformational Folding of Protein Variants in Alzheimer's Disease

What Does Evolution Tell Us About The Structure Of A Functional Amyloid Protein?

AlphaFold and the amyloid landscape

Leveraging AlphaFold 3 for Structural Modeling of Neurological Disorder-Associated Proteins: A Pathway to Precision Medicine

Prediction of protein structure and AI

The power and pitfalls of AlphaFold2 for structure prediction beyond rigid globular proteins

A Perspective on the Prospective Use of AI in Protein Structure Prediction

Severe deviation in protein fold prediction by advanced AI: a case study

What can AlphaFold do for antimicrobial amyloids?

AlzDiscovery: A computational tool to identify Alzheimer's disease-causing missense mutations using protein structure information

A Structural Proteomics Exploration of Synphilin-1 and Alpha-Synuclein Interaction in Pathogenesis of Parkinson's Disease

Unveiling the Structural Proteome of an Alzheimer's Disease Rat Brain Model

Highly accurate protein structure prediction with AlphaFold

Structures prediction and replica exchange molecular dynamics simulations of α-synuclein: A case study for intrinsically disordered proteins

AI-Based Protein Structure Prediction in Drug Discovery: Impacts and Challenges

Unlocking the power of AI models: exploring protein folding prediction through comparative analysis

AlphaFold predictions of fold-switched conformations are driven by structure memorization

Prediction of misfolded proteins spreading in Alzheimer's disease using machine learning and spreading models

Proteins with alternative folds reveal blind spots in AlphaFold-based protein structure prediction

Prediction of peptide structural conformations with AlphaFold2

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.